Every figure on this page comes from documents Bio-Techne filed with the exchange, and each one was checked against the document itself before publication. What could not be verified is not here.
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Mar 2026 | $311 mn | -1.5% | $51 mn | +126.0% | 16.4% |
| Dec 2025 | $296 mn | — | $38 mn | — | 12.8% |
| Sep 2025 | $287 mn | — | $38 mn | — | 13.3% |
| Jun 2025 | $317 mn | — | $-18 mn | — | -5.6% |
| Mar 2025 | $316 mn | — | $23 mn | — | 7.1% |
Watch it, and each morning it files something you get the checked numbers, the sources, and red-flag alerts when the quiet numbers move — pledges, ratings, resignations. Ask by name any evening and it is read overnight.
Start free — first week on us →Data from documents filed with the exchanges, checked against the documents themselves. This page states facts and is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI and verified against filed documents. Terms, disclosures and grievances